{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T08:55:11Z","timestamp":1784364911275,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR069625"],"award-info":[{"award-number":["P30 AR069625"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008328","name":"Austrian Marshall Plan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["BA-3769\/4"],"award-info":[{"award-number":["BA-3769\/4"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Austrian Society for Dermatology and Venereology, Klaus-Wolff fellowship"},{"DOI":"10.13039\/501100006526","name":"\u00d6sterreichische Gesellschaft f\u00fcr Dermatologie und Venerologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006526","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"FWF","doi-asserted-by":"publisher","award":["W1241"],"award-info":[{"award-number":["W1241"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010109","name":"Medizinische Universit\u00e4t Graz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jdermsci.2025.05.006","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T20:28:02Z","timestamp":1748723282000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mast cells express IL17A, IL17F and RORC in lesional psoriatic skin, are activated before therapy and persist in high numbers in a resting state with IL-17A positivity after treatment"],"prefix":"10.1016","volume":"119","author":[{"given":"Theresa","family":"Benezeder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Bordag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Woltsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Teufelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Perchthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Weger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Salmhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gruber-Wackernagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Painsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"El-Heliebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Babina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdermsci.2025.05.006_bib1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.jdermsci.2025.05.006_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaad.2016.11.041","article-title":"Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator\u2013","volume":"76","author":"Blauvelt","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.jdermsci.2025.05.006_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis - results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jdermsci.2025.05.006_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2025.05.006_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00403-008-0874-x","article-title":"Is there a role for mast cells in psoriasis\u00a0?","volume":"300","author":"Harvima","year":"2008","journal-title":"Arch. Dermatol. Res"},{"key":"10.1016\/j.jdermsci.2025.05.006_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187","author":"Lin","year":"2011","journal-title":"J. Immunol."},{"issue":"77","key":"10.1016\/j.jdermsci.2025.05.006_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.abq3254","article-title":"Local IL-23 is required for proliferation and retention of skin-resident memory TH17 cells","volume":"7","author":"Whitley","year":"2022","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.jdermsci.2025.05.006_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri2018","article-title":"Role of mast cells in allergic and non-allergic immune responses: Comparison of human and murine data","volume":"7","author":"Bischoff","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"JAN","key":"10.1016\/j.jdermsci.2025.05.006_bib9","first-page":"1","article-title":"Mast cell: a multi-functional master cell","volume":"6","author":"Krystel-Whittemore","year":"2016","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.jdermsci.2025.05.006_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.it.2017.10.005","article-title":"Mast cells as drivers of disease and therapeutic targets","volume":"39","author":"Siebenhaar","year":"2018","journal-title":"Trends Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jdermsci.2025.05.006_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12016-007-0029-4","article-title":"Mast cells and immunological skin diseases","volume":"33","author":"Navi","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.jdermsci.2025.05.006_bib12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/bjd.20963","article-title":"The biological basis of disease recurrence in psoriasis: a historical perspective and current models","volume":"186","author":"Puig","year":"2022","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.jdermsci.2025.05.006_bib13","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.jid.2018.02.030","article-title":"Resident T cells in resolved psoriasis steer tissue responses that stratify clinical outcome","volume":"138","author":"Gallais S\u00e9r\u00e9zal","year":"2018","journal-title":"J. Invest Dermatol."},{"issue":"17","key":"10.1016\/j.jdermsci.2025.05.006_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173822","article-title":"Skin-resident memory t cells: Pathogenesis and implication for the treatment of psoriasis","volume":"10","author":"Vu","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.jdermsci.2025.05.006_bib15","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1302313","article-title":"Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis","volume":"192","author":"Cheuk","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2025.05.006_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a expression defines tissue-resident CD8 +\u2009T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.jdermsci.2025.05.006_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014108","article-title":"Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis","volume":"5","author":"Res","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2025.05.006_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.56991","article-title":"Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis","volume":"9","author":"Benezeder","year":"2020","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.jdermsci.2025.05.006_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/all.13301","article-title":"Allergic Fc\u03b5RI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF","volume":"73","author":"Babina","year":"2018","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jdermsci.2025.05.006_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1373\/clinchem.2017.281295","article-title":"In situ detection and quantification of AR-V7, AR-FL, PSA, and KRAS point mutations in circulating tumor cells","volume":"64","author":"El-Heliebi","year":"2018","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.jdermsci.2025.05.006_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2044.2004.03757.x","article-title":"Mast cell tryptase: a review of its physiology and clinical significance","volume":"59","author":"Payne","year":"2004","journal-title":"Anaesthesia"},{"issue":"3","key":"10.1016\/j.jdermsci.2025.05.006_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030525","article-title":"Retinoic acid negatively impacts proliferation and MCTC specific attributes of human skin derived mast cells, but reinforces allergic stimulability","volume":"18","author":"Babina","year":"2017","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jdermsci.2025.05.006_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","article-title":"IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis","volume":"130","author":"Krueger","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jdermsci.2025.05.006_bib24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"\u03b2-Defensin 2 is a responsive biomarker of IL-17A\u2013driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.jdermsci.2025.05.006_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.08.046","article-title":"Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes","volume":"124","author":"Zaba","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jdermsci.2025.05.006_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bjd.12937","article-title":"Early tissue responses in psoriasis to the anti-TNF-\u03b1 biologic etanercept suggest reduced IL-17R expression and signalling","volume":"171","author":"Johnston","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.jdermsci.2025.05.006_bib27","first-page":"988","article-title":"Effect of adalimumab on gene expression profiles of psoriatic skin and blood. J Drugs","volume":"15","author":"Chow","year":"2016","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jdermsci.2025.05.006_bib28","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.jaci.2018.11.042","article-title":"Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab","volume":"143","author":"Visvanathan","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"February","key":"10.1016\/j.jdermsci.2025.05.006_bib29","first-page":"1","article-title":"Pathophysiology of skin resident memory T cells","volume":"11","author":"Tokura","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jdermsci.2025.05.006_bib30","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.4049\/jimmunol.1700571","article-title":"Chemokine receptor\u2013dependent control of skin tissue\u2013resident memory T cell formation","volume":"199","author":"Zaid","year":"2017","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jdermsci.2025.05.006_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2021.100094","article-title":"Transcriptomic profiling of plaque psoriasis and cutaneous T-cell subsets during treatment with Secukinumab","volume":"2","author":"Liu","year":"2022","journal-title":"JID Innov."},{"issue":"2117","key":"10.1016\/j.jdermsci.2025.05.006_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-0716-0301-7_7","article-title":"Profiling cell type abundance and expression in bulk tissues with CIBERSORTx","author":"Steen","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.jdermsci.2025.05.006_bib33","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/jid.2013.526","article-title":"In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing ROR\u03b3t and IL-17","volume":"134","author":"Keijsers","year":"2014","journal-title":"J. Invest Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2025.05.006_bib34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.it.2007.03.003","article-title":"Mast cells - key effector cells in immune responses","volume":"28","author":"Metz","year":"2007","journal-title":"Trends Immunol."},{"issue":"September","key":"10.1016\/j.jdermsci.2025.05.006_bib35","first-page":"1","article-title":"IL-17+\u2009Mast cell\/T helper cell axis in the early stages of acne","volume":"12","author":"Eliasse","year":"2021","journal-title":"Front Immunol."},{"issue":"24","key":"10.1016\/j.jdermsci.2025.05.006_bib36","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2009-02-202648","article-title":"Cell-cell cooperation at the T helper cell\/mast cell immunological synapse","volume":"114","author":"Gaudenzio","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jdermsci.2025.05.006_bib37","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jaci.2013.01.029","article-title":"Human mast cells drive memory CD4+\u2009T cells toward an inflammatory IL-22+\u2009phenotype","volume":"131","author":"Gaudenzio","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.05.006_bib38","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/bjd.15358","article-title":"IL-17A localizes in the exocytic compartment of mast cells in psoriatic skin","volume":"177","author":"Brembilla","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"11","key":"10.1016\/j.jdermsci.2025.05.006_bib39","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1172\/JCI93396","article-title":"Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing \u03b1\u03b2 T cell clones","volume":"127","author":"Matos","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.jdermsci.2025.05.006_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12634","article-title":"Mast cells as sources of cytokines, chemokines, and growth factors","volume":"282","author":"Mukai","year":"2018","journal-title":"Immunol. Rev."},{"issue":"170112","key":"10.1016\/j.jdermsci.2025.05.006_bib41","first-page":"1","article-title":"Data descriptor: FANTOM 5 CAGE profiles of human and mouse samples. Nat","volume":"4","author":"Noguchi","year":"2017","journal-title":"Sci. Data"},{"issue":"7","key":"10.1016\/j.jdermsci.2025.05.006_bib42","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4049\/jimmunol.0903566","article-title":"Cutting Edge: Mast cells express IL-17A in rheumatoid arthritis synovium","volume":"184","author":"Hueber","year":"2010","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.jdermsci.2025.05.006_bib43","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00403-014-1488-0","article-title":"Innate immune cells express IL-17A\/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis","volume":"306","author":"Kakeda","year":"2014","journal-title":"Arch. Dermatol. Res"},{"issue":"7","key":"10.1016\/j.jdermsci.2025.05.006_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/exd.12710","article-title":"Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis","volume":"24","author":"Reich","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2025.05.006_bib45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1189\/jlb.3HI1215-542R","article-title":"Human mast cells capture, store, and release bioactive, exogenous IL-17A","volume":"100","author":"Noordenbos","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.jdermsci.2025.05.006_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2023.100198","article-title":"The use of single-Cell RNA-sequencing and spatial transcriptomics in understanding the pathogenesis and treatment of skin diseases","volume":"3","author":"Houser","year":"2023","journal-title":"JID Innov."},{"issue":"6","key":"10.1016\/j.jdermsci.2025.05.006_bib47","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+\u2009T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jdermsci.2025.05.006_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07911-6","article-title":"ROR\u03b3t inhibition selectively targets IL-17 producing iNKT and \u03b3\u03b4-T cells enriched in Spondyloarthritis patients","volume":"10","author":"Venken","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2025.05.006_bib49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF00509232","article-title":"Mast cells and macrophages in early relapsing psoriasis","volume":"277","author":"Schubert","year":"1985","journal-title":"Arch. Dermatol. Res"},{"issue":"5","key":"10.1016\/j.jdermsci.2025.05.006_bib50","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaad.2024.01.014","article-title":"Ixekizumab-induced urticaria is associated with the short duration of remission in psoriasis by activation of mast cells","volume":"90","author":"Zhang","year":"2024","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181125000982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181125000982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:22:43Z","timestamp":1778764963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181125000982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0923181125000982"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2025.05.006","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast cells express IL17A, IL17F and RORC in lesional psoriatic skin, are activated before therapy and persist in high numbers in a resting state with IL-17A positivity after treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2025.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Japanese Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}